Tolero Pharmaceuticals, Inc.
Tolero Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company and a leading developer of novel therapeutics targeting hematologic and oncologic diseases. Tolero Pharmaceuticals is based in the United States and is an indirect, wholly-owned subsidiary of Sumitomo Dainippon Pharma Co., Ltd., a pharmaceutical company based in Japan. Please visit www.ToleroPharma.com.